EPO and stage 5 chronic kidney disease: Furthermore, in patients with end-stage renal disease, i.e., hemodialysis status, NLR was significantly associated with higher erythropoietic resistance, whereas platelet lymphocyte ratio was not associated with erythropoietin responsiveness reflected by erythropoietic resistance, which demonstrated the important predictive role of NLR in the clinical setting [45].